Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Gimme Care vs Luci

Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, Luci a 68. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Gimme Care

#5 · Grade A · Best Value

Est. first month

$130/mo

Save ~90% vs brand-name
Get this deal Full Gimme Care review →
VS

Luci

#281 · Grade C · Watch List

Est. first month

From $99/mo (starting dose, compounded)

Save ~93% vs brand-name
Get this deal Full Luci review →

The verdict

Better value: Gimme Care

Gimme Care takes it on Value Score, 91 to 68 an est. $130/mo first month, with no teaser step-up baked in. Luci isn't out of it: Shoppers who want budget shoppers wanting low-cost compounded semaglutide or tirzepatide, including oral pill options.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealGimme CareLuci
Value Score91 (A)68 (C)
Est. first month$130/moFrom $99/mo (starting dose, compounded)
Save vs brand-name~90%~93%
Semaglutide$130/moFrom $99/mo (starting dose, compounded)
Tirzepatide$163/moFrom $145/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

93
Lowest Real Price
90
Gimme Care: 93. Luci: 90.
88
No Teaser-Rate Bait
30
Gimme Care: 88. Luci: 30.
98
Nationwide Availability
45
Gimme Care: 98. Luci: 45.
92
Both Molecules
98
Gimme Care: 92. Luci: 98.
84
Easy Cancellation
58
Gimme Care: 84. Luci: 58.
82
Reputation
68
Gimme Care: 82. Luci: 68.

Gimme Care

Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.

Why it's a deal

  • Low flat price on both molecules ($130 sema / $163 tirz)
  • LegitScript-certified pharmacy
  • Available in all 50 states

The fine print

  • No brand-name option — compounded only
  • No oral/sublingual form

Luci

Luci is a budget-focused GLP-1 telehealth platform offering compounded medications with upfront pricing: compounded semaglutide as low as $99/month and compounded tirzepatide as low as $145/month, plus oral…

Why it's a deal

  • Budget-friendly compounded GLP-1 pricing (compounded semaglutide as low as $99/month, tirzepatide as low as $145/month)
  • Multiple formats: compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits
  • Upfront pricing with no insurance required and a fast 3-minute questionnaire to start
  • Care delivered through DrTelx, an independent US telehealth medical group, with ongoing support and dose optimization
  • HIPAA-compliant platform with a large self-reported member base (50,000+)

The fine print

  • Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Available only in select U.S. states, and the full state list is not published
  • The compounding pharmacy partner is not named
  • Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher
  • No LegitScript certification displayed; marketing leans heavily on testimonials
Get the Gimme Care deal Get the Luci deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to Luci.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.